Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.2 replaces the previous v3.6.0 on the page, signaling an updated release of the platform or page template rather than a substantive change to study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNew help and navigation sections were added to the study details page, including How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment heading formatting was adjusted and revision information updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check27 days agoChange DetectedThe page shows a new revision label, updating from Revision: v3.5.4 to Revision: v3.5.5, indicating a system/template update. This change does not modify the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision tag Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's versioning metadata. This indicates a maintenance update to the page's documentation rather than changes to study content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a small internal version update to the page. There are no changes to the study data or displayed content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision was updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.